|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.18 BRL | -4.75% |
|
-5.91% | +3.09% |
| 09/07 | Vale Shares Fall After Morgan Stanley Downgrade | MT |
| 08/07 | Morgan Stanley Downgrades Vale to Equal Weight From Overweight, Cuts Price Target to $16.50 From $19.50 | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 21.18 | 12.65 | 10.04 | 7.63 | 7.79 | |||||
Return on Total Capital | 35.36 | 21.19 | 16.44 | 12.05 | 12.05 | |||||
Return On Equity % | 70.8 | 44.15 | 20.63 | 14.77 | 5.87 | |||||
Return on Common Equity | 70.71 | 45.38 | 21.13 | 15.89 | 7.06 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 60.05 | 45.17 | 42.32 | 36.25 | 34.98 | |||||
SG&A Margin | 0.89 | 1.17 | 1.33 | 1.65 | 1.67 | |||||
EBITDA Margin % | 61.64 | 49.18 | 41.89 | 35.61 | 35.99 | |||||
EBITA Margin % | 56.84 | 43.07 | 35.69 | 28.93 | 29.13 | |||||
EBIT Margin % | 56.41 | 42.55 | 35.09 | 28.22 | 28.36 | |||||
Income From Continuing Operations Margin % | 45.59 | 38.2 | 19.49 | 14.77 | 5.53 | |||||
Net Income Margin % | 41.3 | 42.35 | 19.2 | 15.34 | 6.47 | |||||
Net Avail. For Common Margin % | 45.55 | 38.01 | 19.2 | 15.34 | 6.47 | |||||
Normalized Net Income Margin | 37.49 | 30.14 | 17.12 | 11.37 | 16.87 | |||||
Levered Free Cash Flow Margin | 31.83 | 17.67 | 3.23 | 20.21 | 7.23 | |||||
Unlevered Free Cash Flow Margin | 33.46 | 18.79 | 5.2 | 22.32 | 11.72 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.6 | 0.48 | 0.46 | 0.43 | 0.44 | |||||
Fixed Assets Turnover | 1.31 | 0.97 | 0.89 | 0.85 | 0.88 | |||||
Receivables Turnover (Average Receivables) | 12.29 | 10.21 | 9.71 | 11.8 | 15.68 | |||||
Inventory Turnover (Average Inventory) | 5.15 | 5.19 | 5.21 | 5.13 | 4.54 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.47 | 1.12 | 1.28 | 1.03 | 1.15 | |||||
Quick Ratio | 1.1 | 0.75 | 0.6 | 0.65 | 0.72 | |||||
Operating Cash Flow to Current Liabilities | 1.61 | 0.8 | 0.93 | 0.62 | 0.56 | |||||
Days Sales Outstanding (Average Receivables) | 29.71 | 35.76 | 37.59 | 31.02 | 23.27 | |||||
Days Outstanding Inventory (Average Inventory) | 70.86 | 70.26 | 70.05 | 71.34 | 80.39 | |||||
Average Days Payable Outstanding | 55.83 | 63.23 | 74.65 | 69.04 | 72.52 | |||||
Cash Conversion Cycle (Average Days) | 44.74 | 42.78 | 32.99 | 33.32 | 31.15 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 50.72 | 41.33 | 41 | 51.35 | 61.33 | |||||
Total Debt / Total Capital | 33.65 | 29.24 | 29.08 | 33.93 | 38.01 | |||||
LT Debt/Equity | 46.87 | 40.02 | 38.51 | 47.97 | 59.35 | |||||
Long-Term Debt / Total Capital | 31.1 | 28.32 | 27.31 | 31.69 | 36.79 | |||||
Total Liabilities / Total Assets | 60.52 | 57.01 | 56.51 | 56.94 | 60.32 | |||||
EBIT / Interest Expense | 21.69 | 23.91 | 11.15 | 8.36 | 3.95 | |||||
EBITDA / Interest Expense | 23.83 | 27.87 | 13.45 | 10.7 | 5.06 | |||||
(EBITDA - Capex) / Interest Expense | 20.25 | 20.88 | 8.96 | 5.65 | 2.88 | |||||
Total Debt / EBITDA | 0.55 | 0.72 | 0.92 | 1.48 | 1.49 | |||||
Net Debt / EBITDA | 0.18 | 0.49 | 0.72 | 1.06 | 0.96 | |||||
Total Debt / (EBITDA - Capex) | 0.65 | 0.96 | 1.39 | 2.79 | 2.62 | |||||
Net Debt / (EBITDA - Capex) | 0.21 | 0.66 | 1.08 | 2 | 1.68 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 42.42 | -22.83 | -8.14 | -0.99 | 3.68 | |||||
Gross Profit, 1 Yr. Growth % | 53.07 | -41.95 | -13.94 | -15.18 | 0.03 | |||||
EBITDA, 1 Yr. Growth % | 52.9 | -38.47 | -17.32 | -15.83 | 4.91 | |||||
EBITA, 1 Yr. Growth % | 61.7 | -41.56 | -18.91 | -19.74 | 4.54 | |||||
EBIT, 1 Yr. Growth % | 61.88 | -41.82 | -19.24 | -20.37 | 4.35 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 296.2 | -35.35 | -53.13 | -24.96 | -61.19 | |||||
Net Income, 1 Yr. Growth % | 353.82 | -20.87 | -58.36 | -20.9 | -56.27 | |||||
Normalized Net Income, 1 Yr. Growth % | 133.16 | -37.99 | -44.81 | -34.25 | 54.29 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 284.5 | -30.4 | -50.73 | -19.32 | -56.23 | |||||
Accounts Receivable, 1 Yr. Growth % | -15.82 | 3.19 | -9.85 | -28.14 | -13.43 | |||||
Inventory, 1 Yr. Growth % | 15.76 | -4.27 | -3.02 | 25.72 | 14.57 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 9.43 | 0.2 | -0.07 | 5.67 | -3.05 | |||||
Total Assets, 1 Yr. Growth % | 4.39 | -9.16 | 0.57 | 8.85 | -4.08 | |||||
Tangible Book Value, 1 Yr. Growth % | 3.38 | -5.93 | 0.72 | 5.21 | -4.68 | |||||
Common Equity, 1 Yr. Growth % | 3.56 | -2.75 | 2.06 | 8.28 | -10.87 | |||||
Cash From Operations, 1 Yr. Growth % | 81.85 | -57.44 | 13.24 | -23.83 | -2.86 | |||||
Capital Expenditures, 1 Yr. Growth % | 25.7 | 3.23 | 4.48 | 19.19 | -4.87 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 70.36 | -57.42 | -81.41 | 519.84 | -57.91 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 57.01 | -56.93 | -72.15 | 325.33 | -45.47 | |||||
Dividend Per Share, 1 Yr. Growth % | 111.32 | -59.62 | 22.81 | -31.94 | 15.13 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 42.46 | 4.83 | -15.81 | -4.63 | 1.32 | |||||
Gross Profit, 2 Yr. CAGR % | 60.76 | -5.74 | -29.32 | -14.56 | -7.89 | |||||
EBITDA, 2 Yr. CAGR % | 58.55 | -3.38 | -27.9 | -15.21 | -8.93 | |||||
EBITA, 2 Yr. CAGR % | 69.38 | -2.55 | -29.94 | -16.58 | -10.33 | |||||
EBIT, 2 Yr. CAGR % | 68.72 | -3.14 | -30.53 | -17.61 | -11.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 731.85 | 60.04 | -44.95 | -40.69 | -46.03 | |||||
Net Income, 2 Yr. CAGR % | 326.26 | 89.5 | -42.6 | -42.61 | -41.19 | |||||
Normalized Net Income, 2 Yr. CAGR % | 94.62 | 20.21 | -40.65 | -38.34 | -3.04 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 487.81 | 63.59 | -41.43 | -36.95 | -40.58 | |||||
Accounts Receivable, 2 Yr. CAGR % | 46.36 | -6.8 | -3.55 | -19.51 | -21.13 | |||||
Inventory, 2 Yr. CAGR % | 19.08 | 5.27 | -3.65 | 10.42 | 20.02 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 11.64 | 4.71 | 0.07 | 2.76 | 1.22 | |||||
Total Assets, 2 Yr. CAGR % | 16.2 | -2.62 | -4.42 | 4.63 | 2.18 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.69 | -1.39 | -2.66 | 2.94 | 0.14 | |||||
Common Equity, 2 Yr. CAGR % | 9.16 | 0.36 | -0.37 | 5.12 | -1.76 | |||||
Cash From Operations, 2 Yr. CAGR % | 70.08 | -12.03 | -30.58 | -7.13 | -13.98 | |||||
Capital Expenditures, 2 Yr. CAGR % | 40.54 | 13.91 | 3.85 | 11.59 | 6.49 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 34.03 | -14.43 | -71.85 | 11.71 | 91.07 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 30.01 | -17.41 | -65.29 | 12.94 | 36.02 | |||||
Dividend Per Share, 2 Yr. CAGR % | 215.67 | -7.63 | -29.58 | -8.58 | -11.46 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 29.72 | 16.13 | 0.32 | -11.13 | -1.94 | |||||
Gross Profit, 3 Yr. CAGR % | 49 | 14.48 | -8.56 | -24.89 | -9.95 | |||||
EBITDA, 3 Yr. CAGR % | 45.46 | 15.67 | -9.94 | -24.09 | -9.01 | |||||
EBITA, 3 Yr. CAGR % | 53.04 | 18.82 | -10.25 | -26.69 | -10.11 | |||||
EBIT, 3 Yr. CAGR % | 52.65 | 18.34 | -10.76 | -27.3 | -10.9 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 72.47 | 254.99 | 6.28 | -38.96 | -48.51 | |||||
Net Income, 3 Yr. CAGR % | 67.8 | 143.16 | 14.35 | -36.13 | -47.58 | |||||
Normalized Net Income, 3 Yr. CAGR % | 83.12 | 32.95 | -8.99 | -38.59 | -16.36 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 74.56 | 188.64 | 9.66 | -34.83 | -44.18 | |||||
Accounts Receivable, 3 Yr. CAGR % | 28.63 | 30.27 | -7.83 | -12.56 | -17.53 | |||||
Inventory, 3 Yr. CAGR % | 12.37 | 10.72 | 2.43 | 5.29 | 11.78 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.67 | 7.69 | 3.09 | 1.9 | 0.79 | |||||
Total Assets, 3 Yr. CAGR % | 13.46 | 7.04 | -1.57 | -0.19 | 1.64 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.61 | 1.67 | -0.69 | -0.11 | 0.33 | |||||
Common Equity, 3 Yr. CAGR % | 4.13 | 5.03 | 0.92 | 2.43 | -0.5 | |||||
Cash From Operations, 3 Yr. CAGR % | 41.97 | 7.17 | -4.31 | -28.4 | -5.73 | |||||
Capital Expenditures, 3 Yr. CAGR % | 25.24 | 26.81 | 10.68 | 8.73 | 5.81 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 58.64 | -8.36 | -50.29 | -21.11 | -22.64 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 53.29 | -9.86 | -44.25 | -19.97 | -11.43 | |||||
Dividend Per Share, 3 Yr. CAGR % | 111.94 | 59.05 | 1.57 | -30.38 | -1.27 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 25.41 | 15.85 | 9.12 | 7.33 | 0.72 | |||||
Gross Profit, 5 Yr. CAGR % | 39.39 | 19.91 | 10.57 | 1.83 | -8.29 | |||||
EBITDA, 5 Yr. CAGR % | 35.66 | 18.44 | 8.19 | 0.38 | -8.42 | |||||
EBITA, 5 Yr. CAGR % | 43.65 | 22.1 | 9.79 | 0.49 | -9.54 | |||||
EBIT, 5 Yr. CAGR % | 43.43 | 21.8 | 9.42 | -0.01 | -10.03 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 50.29 | 33.66 | 9.23 | 73.53 | -18.95 | |||||
Net Income, 5 Yr. CAGR % | 55.55 | 40.33 | 9.25 | 36.48 | -12.36 | |||||
Normalized Net Income, 5 Yr. CAGR % | 42.12 | 32.68 | 14.73 | -4.22 | -5.27 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 51.33 | 36.67 | 12.77 | 57.07 | -14.18 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.84 | 21.24 | 14.64 | 7.45 | -13.4 | |||||
Inventory, 5 Yr. CAGR % | 17.49 | 12.48 | 5.67 | 10.6 | 9.13 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.32 | 5.25 | 4.56 | 5.69 | 2.34 | |||||
Total Assets, 5 Yr. CAGR % | 9.11 | 6.68 | 5.94 | 6.07 | -0.09 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.27 | 2.94 | -0.71 | 2.17 | -0.36 | |||||
Common Equity, 5 Yr. CAGR % | 8.62 | 5.41 | 2.3 | 5.07 | -0.16 | |||||
Cash From Operations, 5 Yr. CAGR % | 44.6 | 8.25 | 6.64 | 1.2 | -8.3 | |||||
Capital Expenditures, 5 Yr. CAGR % | 9.5 | 18.16 | 16.2 | 20.49 | 8.98 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 97.55 | 2.21 | -22.09 | -4.36 | -22.34 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 136.25 | 0.96 | -16.89 | -4.57 | -16.69 | |||||
Dividend Per Share, 5 Yr. CAGR % | 67.41 | 44.34 | 36.4 | 27.45 | -3.86 |
- Stock Market
- Stocks
- VALE3 Stock
- Financials Vale S.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















